Skip to main content
Top
Published in: Infection 3/2018

01-06-2018 | Original Paper

Outpatient parenteral antibiotic therapy in a suburban tertiary referral centre in Australia over 10 years

Authors: Wenlong Li, James Branley, Archana Sud

Published in: Infection | Issue 3/2018

Login to get access

Abstract

Purpose

Outpatient parenteral antibiotic therapy (OPAT) is a widely accepted and safe therapeutic option for carefully selected patients. This study reviewed the practice of an OPAT service in a large Australian tertiary teaching hospital in Western Sydney over a 10-year period.

Method

Data were retrieved from a prospectively maintained electronic database which included information on patient demographics, clinical diagnosis, microbiological identity, antimicrobial therapy, complications and readmissions. Data were analysed using descriptive statistics.

Results

There were 3435 referrals made to the service between January 2004 and June 2014, amounting to 25,289 antibiotic days. The most frequent referral was for Skin and Soft Tissue Infections (SSTIs), 61.28%, followed by Bone and Joint Infections (BJIs), 15.30%. The most common organism identified was methicillin-sensitive Staphylococcus aureus. Readmission was uncommon (5.15%), with the highest rate of readmission noted for Cardiovascular System Infections (16.67%) followed by BJIs (10.31%). Line infection, aseptic thrombophlebitis and drug hypersensitivity or reaction were the cause of 68.55% of all complications. There was a decline in line-related complications throughout the study period.

Conclusion

OPAT service is in increasing demand in Australia, providing a significant relief in in-hospital days. Growth in referrals was seen not only with SSTIs and BJIs, but also a diverse range of other infective entities with limited literature in its treatment in an OPAT setting. This study highlights the need to improve data collection, develop risk stratification strategies and standardisation of OPAT services in Australia.
Literature
1.
go back to reference Rucker RW, Harrison GM. Outpatient intravenous medications in the management of cystic fibrosis. Pediatrics. 1974;54:358–60.PubMed Rucker RW, Harrison GM. Outpatient intravenous medications in the management of cystic fibrosis. Pediatrics. 1974;54:358–60.PubMed
2.
go back to reference Caplan GA, Sulaiman NS, Mangin DA, Aimonino Ricauda N, Wilson AD, Barclay L. A meta-analysis of “hospital in the home”. The Med J Aus. 2012;197:512–9.CrossRef Caplan GA, Sulaiman NS, Mangin DA, Aimonino Ricauda N, Wilson AD, Barclay L. A meta-analysis of “hospital in the home”. The Med J Aus. 2012;197:512–9.CrossRef
5.
go back to reference Grayson ML, Silvers J, Turnidge J. Home intravenous antibiotic therapy. a safe and effective alternative to inpatient care. The Medi J Aus. 1995;162:249–53. Grayson ML, Silvers J, Turnidge J. Home intravenous antibiotic therapy. a safe and effective alternative to inpatient care. The Medi J Aus. 1995;162:249–53.
9.
go back to reference Ingram PR, Cerbe L, Hassell M, Wilson M, Dyer JR. Limited role for outpatient parenteral antibiotic therapy for community-acquired pneumonia. Respirology. 2008;13:893–6.CrossRefPubMed Ingram PR, Cerbe L, Hassell M, Wilson M, Dyer JR. Limited role for outpatient parenteral antibiotic therapy for community-acquired pneumonia. Respirology. 2008;13:893–6.CrossRefPubMed
12.
go back to reference Relationships System, Branch Frameworks. New South Wales hospital in the home (HITH) guideline. North Sydney: New South Wales Ministry of Health; 2013. Relationships System, Branch Frameworks. New South Wales hospital in the home (HITH) guideline. North Sydney: New South Wales Ministry of Health; 2013.
13.
go back to reference Queensland Department of Health. Hospital in the Home (HITH) Guideline #QH-GDL-379:2016. 2013 (Last Editted 2017). Queensland Department of Health. Hospital in the Home (HITH) Guideline #QH-GDL-379:2016. 2013 (Last Editted 2017).
14.
go back to reference Chopra V, Flanders SA, Saint S, Woller SC, O’Grady NP, Safdar N, et al. The michigan appropriateness guide for intravenous catheters (MAGIC): results from a multispecialty panel using the RAND/UCLA appropriateness method. Ann Intern Med. 2015;163:S1–40. https://doi.org/10.7326/m15-0744.CrossRefPubMed Chopra V, Flanders SA, Saint S, Woller SC, O’Grady NP, Safdar N, et al. The michigan appropriateness guide for intravenous catheters (MAGIC): results from a multispecialty panel using the RAND/UCLA appropriateness method. Ann Intern Med. 2015;163:S1–40. https://​doi.​org/​10.​7326/​m15-0744.CrossRefPubMed
21.
go back to reference Osteomyelitis [revised 2015 Oct]. In: eTG complete [Internet]. Melbourne: Therapeutic Guidelines Limited; 2017 Nov. Osteomyelitis [revised 2015 Oct]. In: eTG complete [Internet]. Melbourne: Therapeutic Guidelines Limited; 2017 Nov.
Metadata
Title
Outpatient parenteral antibiotic therapy in a suburban tertiary referral centre in Australia over 10 years
Authors
Wenlong Li
James Branley
Archana Sud
Publication date
01-06-2018
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 3/2018
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-018-1126-4

Other articles of this Issue 3/2018

Infection 3/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.